172 related articles for article (PubMed ID: 29597092)
41. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
Li X; Xu R; Liu H; Fang K
Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
[TBL] [Abstract][Full Text] [Related]
42. G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail.
Wang Z; Chen X; Zhao Y; Jin Y; Zheng J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):87-96. PubMed ID: 30341688
[TBL] [Abstract][Full Text] [Related]
43. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
[No Abstract] [Full Text] [Related]
44. Suppression of YAP by DDP disrupts colon tumor progression.
Li K; Guo J; Wu Y; Jin D; Jiang H; Liu C; Qin C
Oncol Rep; 2018 May; 39(5):2114-2126. PubMed ID: 29512779
[TBL] [Abstract][Full Text] [Related]
45. PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity.
Basu-Roy U; Han E; Rattanakorn K; Gadi A; Verma N; Maurizi G; Gunaratne PH; Coarfa C; Kennedy OD; Garabedian MJ; Basilico C; Mansukhani A
Oncotarget; 2016 Sep; 7(38):60954-60970. PubMed ID: 27528232
[TBL] [Abstract][Full Text] [Related]
46. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
Fan Y; Li M; Ma K; Hu Y; Jing J; Shi Y; Li E; Dong D
Cancer Biol Ther; 2019; 20(5):617-632. PubMed ID: 30462562
[TBL] [Abstract][Full Text] [Related]
47. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
48. Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity.
Yao Q; Yang J; Liu T; Zhang J; Zheng Y
FEBS Open Bio; 2019 Aug; 9(8):1392-1402. PubMed ID: 31116509
[TBL] [Abstract][Full Text] [Related]
49. LINC00668 cooperated with HuR dependent upregulation of PKN2 to facilitate gastric cancer metastasis.
Li J; Dong W; Jiang Q; Zhang F; Dong H
Cancer Biol Ther; 2021 Apr; 22(4):311-323. PubMed ID: 33879018
[TBL] [Abstract][Full Text] [Related]
50. Knockdown of neuropilin-1 suppresses invasion, angiogenesis, and increases the chemosensitivity to doxorubicin in osteosarcoma cells - an in vitro study.
Yue B; Ma JF; Yao G; Yang MD; Cheng H; Liu GY
Eur Rev Med Pharmacol Sci; 2014; 18(12):1735-41. PubMed ID: 24992616
[TBL] [Abstract][Full Text] [Related]
51. The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm.
Wu X; Wang Y; Zhong W; Cheng H; Tian Z
Med Sci Monit; 2020 May; 26():e922012. PubMed ID: 32433460
[TBL] [Abstract][Full Text] [Related]
52. Circular RNA circPIP5K1A contributes to cancer stemness of osteosarcoma by miR-515-5p/YAP axis.
Shi P; Li Y; Guo Q
J Transl Med; 2021 Nov; 19(1):464. PubMed ID: 34774083
[TBL] [Abstract][Full Text] [Related]
53. Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer.
Ling HH; Kuo CC; Lin BX; Huang YH; Lin CW
Exp Cell Res; 2017 Jan; 350(1):218-225. PubMed ID: 27914787
[TBL] [Abstract][Full Text] [Related]
54. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
Wang X; Hu K; Chao Y; Wang L
Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
[TBL] [Abstract][Full Text] [Related]
55. CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling.
Lai CJ; Lin CY; Liao WY; Hour TC; Wang HD; Chuu CP
Cells; 2019 Mar; 8(4):. PubMed ID: 30935014
[TBL] [Abstract][Full Text] [Related]
56. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA.
Zhang Z; Huang A; Zhang A; Zhou C
Biomed Pharmacother; 2017 Jul; 91():788-795. PubMed ID: 28501005
[TBL] [Abstract][Full Text] [Related]
57. IL-6 Triggers the Migration and Invasion of Oestrogen Receptor-Negative Breast Cancer Cells via Regulation of Hippo Pathways.
Hou L; Xie S; Li G; Xiong B; Gao Y; Zhao X; Hu J; Deng S; Jiang J
Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):549-557. PubMed ID: 29781562
[TBL] [Abstract][Full Text] [Related]
58. VEGFR2 and VEGF-C Suppresses the Epithelial-Mesenchymal Transition Via YAP in Retinal Pigment Epithelial Cells.
Du Y; Chen Q; Huang L; Wang S; Yin X; Zhou L; Ye Z; Ren X; Cai Y; Ding X; Ouyang H; Li X; Ju R
Curr Mol Med; 2018; 18(5):273-286. PubMed ID: 30289073
[TBL] [Abstract][Full Text] [Related]
59. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
[TBL] [Abstract][Full Text] [Related]
60. miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b.
Liu Q; Wang Z; Zhou X; Tang M; Tan W; Sun T; Deng Y
Cell Cycle; 2019 Dec; 18(23):3325-3336. PubMed ID: 31601147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
